Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
Cancer medicine (Malden, MA), 2020-04, Vol.9 (7), p.2390-2402
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Modifying factors of PD‐L1 expression on tumor cells in advanced non‐small‐cell lung cancer
Thoracic cancer, 2022-12, Vol.13 (23), p.3362-3373
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status
Thoracic cancer, 2020-04, Vol.11 (4), p.1026-1037
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
Journal of Immunology Research, 2021, Vol.2021, p.6632249-9
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A phase II study of alectinib in combination with bevacizumab as first-line treatment in advanced NSCLC with confirmed ALK fusion: ALEK-B trial
Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9074-9074
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC
Journal of thoracic oncology, 2024-01, Vol.19 (1), p.119-129
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Nitroglycerin (NTG) plus whole intracranial radiotherapy for brain metastases (BM) in non-small cell cancer patient (NSCLC): A randomized open label, phase II clinical trial
Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9114-9114
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Cell-Free Circulating Tumor DNA Improves Standard Genotyping of Non-Small-Cell Lung Cancer and Increases Detection of Targetable Alterations in a Selected Hispanic Cohort
Oncology, 2021-07, Vol.99 (8), p.539-546
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Combination of metformin plus TKI vs. TKI alone in EGFR(+) LUNG adenocarcinoma: A randomized phase II study
Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.9013-9013
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America
Oncology, 2019-04, Vol.96 (4), p.207-216
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Response Assessment of 68 Ga-DOTA-E-[c(RGDfK)] 2 PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel
Journal of Nuclear Medicine, 2018-03, Vol.59 (3), p.403-409
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Response Assessment of 68Ga-DOTA-E-[c(RGDfK)]2 PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel
The Journal of nuclear medicine (1978), 2018-03, Vol.59 (3), p.403-409
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Response Assessment of ^sup 68^Ga-DOTA-E-[c(RGDfK)]^sup 2^ PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel
The Journal of nuclear medicine (1978), 2018-03, Vol.59 (3), p.403
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells
Pathology oncology research, 2021-04, Vol.27, p.597499-597499
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer
American journal of clinical oncology, 2017-12, Vol.40 (6), p.631-638
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
P2.03b-083 Soluble Angiogenic Factors as Predictive Biomarkers of Response to Docetaxel plus Nintedanib as Second Line Therapy in NSCLC: Topic: Biomarkers
Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S986-S986
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
P2.03b-088 PET-CT with 68Ga-RGD as Biomarker of Response to Nintedanib plus Docetaxel as Second Line Therapy in NSCLC
Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S989-S990
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
P2.03b-088 PET-CT with 68Ga-RGD as Biomarker of Response to Nintedanib plus Docetaxel as Second Line Therapy in NSCLC: Topic: Biomarkers
Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S989-S990
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
P2.03b-083 Soluble Angiogenic Factors as Predictive Biomarkers of Response to Docetaxel plus Nintedanib as Second Line Therapy in NSCLC
Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S986
2017
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial
Targeted oncology, 2016-10, Vol.11 (5), p.619-629
2016
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Personalized treatment in non-small cell lung cancer
Revista de investigacion clinica, 2012-07, Vol.64 (4), p.377-386
2012
Volltextzugriff (PDF)
1 – 21 von 21
Suche als RSS-Feed
Aktive Filter
Nur zeigenGeprüft (Peer-Review)
Suchergebnisse filtern
Filter anzeigen